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Abstract Protein phosphorylation was studied during platelet
stimulation in two ranges of ionized [Ca2+]. At ionized
[Ca2+]i 91 WM, proteins were phosphorylated. At ionized
[Ca2+]iv4 WM, phosphoproteins disappeared. Protein depho-
sphorylation was prevented by the combined action of calpeptin
and phosphatase inhibitors. Protein tyrosine phosphatase activity
was stimulated regardless of the ionized [Ca2+]i level. Protein
tyrosine kinase activity was stimulated at ionized [Ca2+]i9 1 WM,
whereas at ionized [Ca2+]iv4 WM, no protein tyrosine kinase
activity was observed except in the presence of calpeptin. Thus,
the massive tyrosine phosphoprotein disappearance observed at a
high ionized [Ca2+]i resulted not only in protein tyrosine
phosphatase activation, but also in calpain-induced protein
tyrosine kinase inactivation.
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1. Introduction
As for many di¡erent cell types, calcium is a key mediator
for stimulus-response coupling in platelets. Elevation of plate-
let ionized cytosolic calcium ([Ca2]i) is the result of a ca-
pacitative system consisting of depletion of intracellular stores
and in£ux from the external medium [1,2]. Depending on the
agonist, [Ca2]i is elevated at di¡erent levels and activates
di¡erent e¡ector enzyme(s). Phospholipase A2, myosin light
chain kinase and protein kinase C require a lower [Ca2]i [3]
than do the lipid scramblase [4] or the cysteine protease cal-
pain to be autolysed [5]. An increase in tyrosine protein phos-
phatase (PTP) activity was recently reported for stimulating
conditions involving high [Ca2]i [6].
Calcium ionophores, which bypass receptor-coupling mech-
anisms and carry calcium within cells through membranes,
represent useful tools to evoke changes in [Ca2]i and the
impact of di¡erent [Ca2]i on platelet activation. Ionophores
can evoke increases in [Ca2]i, large enough to stimulate the
lipid scramblase and calpain autolysis. There are, however,
puzzling data concerning phosphorylation or dephosphoryla-
tion of tyrosine proteins following stimulation by ionophores
[6^9]. All reports show protein phosphorylation pro¢les, but
no measure of kinase or phosphatase activities have been
performed.
In this context, we studied protein phosphorylation during
platelet activation at high [Ca2]i. We used ionophores in the
presence of calcium and measured protein tyrosine kinase
(PTK) and PTP activities in the presence of a calpain inhib-
itor. The results show that during platelet activation at
[Ca2]iv 4 WM, phosphorylated proteins disappear as a result
of PTP activation and, above all, of simultaneous calpain-
induced PTK inactivation.
2. Materials and methods
2.1. Materials
Calpeptin was from Novabiochem (La«ufel¢ngen, Switzerland), oka-
daic acid (OA) from RBI (Natick, MA, USA), metrizamide and para-
nitrophenyl phosphate (pNPP) were from Sigma (Saint Louis, MO,
USA). Electrophoresis reagents were from Bio-Rad (Hercules, CA,
USA). All other chemicals were of the highest purity grade. Pervana-
date was prepared by addition of a solution (1:1 v/v) of vanadate
20 mM to H2O2 0.07%. Since ionophores are insoluble in water and
unstable, a stock solution (1 mM in Me2SO) was kept at 320‡C and
freshly diluted in Me2SO each time so that vehicle was added at less
than 0.5% of the platelet volume. All results were performed in paral-
lel with A23187 (Sigma) and ionomycin (Calbiochem, La Jolla, CA,
USA). Ionomycin was twice as e⁄cient as A23187, inducing the same
e¡ects as A23187 at 2-fold lower concentrations, in keeping with the
stoichiometric properties of the two ionophores as calcium carriers
[10,11].
2.2. Platelet preparation and stimulation
Fresh platelet concentrates were obtained from local transfusion
centers. Platelets were isolated by means of metrizamide gradients,
as previously described [12], resuspended in a solution consisting of
10 mM HEPES, 140 mM NaCl, 3 mM KCl, 0.5 mM MgCl2, 5 mM
NaHCO3, 10 mM glucose, 2 mM CaCl2, pH 7.4, and adjusted to
3U108 cells/ml. Stimulation was performed at 37‡C in the cuvette
of an aggregometer (Chronolog, Haverton, PA, USA) under constant
stirring (1100 rpm).
2.3. [Ca2+]i measurement
Washed platelets were incubated for 45 min at 37‡C with 5 WM of
the £uorescent intracellular calcium indicator fura-2 (acetoxymethyl
ester form, Molecular Probes, Eugene, OR, USA) before being cen-
trifuged and resuspended at a concentration of 3U108 cells/ml in the
same solution as indicated above. Fura-2 £uorescence was monitored
using a Shimadzu RF-5001 PC spectro£uorimeter (Kyoto, Japan).
Excitation wavelengths were 340 and 380 nm and the emission wave-
length was 495 nm. The [Ca2]i was calculated according to Grynkie-
wicz et al. [13] with a dissociation constant (Kd) of 224 nM for Ca2.
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2.4. Protein phosphorylation
Platelets were incubated for 60 min at 37‡C with [32P]phosphoric
acid (NEN, Boston, MA, USA, 8500^9120 Ci/mmol, 100 WCi/ml
platelet suspension) before the last wash and resuspended as above.
After stimulation, platelets were solubilized in Laemmli bu¡er con-
taining 2% sodium dodecyl sulfate (SDS) and 1 mM EDTA and
proteins were separated on SDS-polyacrylamide gel electrophoresis
(SDS-PAGE) using a 13% gel. Proteins were stained with Coomassie
blue and the gels were dried and autoradiographed on Hyper¢lm MP
(Amersham, Buckinghamshire, UK). Analysis of phosphotyrosine
proteins was performed on unlabelled platelets, separated by SDS-
PAGE on a 7% gel and transferred to a PDVF membrane (Millipore
Corp, Bedford, MA, USA). Membranes were incubated with 4G10
antibody (UBI, Lake Placid, NY, USA) for 2 h as previously
described [12] and phosphotyrosine proteins were visualized by
enhanced chemiluminescence (ECL and hyper¢lm-ECL, Amersham).
2.5. Assay of platelet PTP and PTK activities in platelet lysates
Platelets were lysed by incubation with 0.5 volume of 3U concen-
trated lysis bu¡er (3% NP-40, 150 mM Tris-HCl, pH 7.4, 450 mM
NaCl, 3 mM EGTA, 3 mM PMSF, 15 Wg/ml leupeptin and 15 Wg/ml
aprotinin) for 30 min at 4‡C. PTP activity was measured for 200 Wl
aliquots of platelet lysates incubated (v/v) with the reaction mixture
(HEPES, 62 mM, pH 7.5) containing 8 mM pNPP as the substrate,
1 WM OA to inhibit serine/threonine phosphatases. Duplicates were
performed in the presence of 1 mM pervanadate in the reaction mix-
ture in order to be sure that the measured phosphatase activity was
speci¢cally due to tyrosine phosphatases. The absorbance change, due
to conversion of pNPP to pNP, was registered for 1 h at room tem-
perature at 405 nm using a microplate reader (Dynatech MR5000,
Guernesey, IL, USA). PTK activity was measured for 250 Wl aliquots
of platelet lysates incubated for 30 min at 37‡C in Tris bu¡er (50 mM,
pH 7.5, containing 5 mM sodium acetate, 0.2 mM EDTA, 0.8 mM
EGTA, 3 mM DTT, 30 WM vanadate, 1 mM ATP) with 1 WM biotin-
labelled tyrosine containing peptide (biotin-KVEKIGEGTYGVVYK-
amide) as the substrate (Pierce, Rockford, IL, USA). The reaction was
quenched by piceatannol (Sigma, 600 WM to inhibit all PTKs), trans-
fer at 4‡C and centrifugation for 1 min at 12 000Ug. The phosphoryl-
ated substrate was immobilized on a streptavidin-coated microtiter
plate and the reaction mixture was washed out. The fraction of phos-
phorylated substrate was quanti¢ed by using a peroxidase-conjugated
anti-phosphotyrosine antibody and measuring the absorbance by a
dual wavelength mode (405/490 nm).
3. Results
3.1. [Ca2+]i increase induced by ionophores
[Ca2]i was measured on fura-2-loaded platelets, in the
presence of 2 mM external calcium (Fig. 1). The basal
[Ca2]i was 60^100 nM. Stimulation by 0.05 WM ionomycin
(left tracing) increased [Ca2]i progressively in the ¢rst few
seconds. It reached 300 nM at 1 min and a maximum level
of 350^700 nM depending on the donor. Using 0.5 WM ion-
omycin (right tracing), the increase was extremely rapid and
[Ca2]i reached 1 WM at 10 s, 2 WM at 15 s and over 4 WM at
30 s. Similar results were obtained with £uo-3-loaded platelets
stimulated by A23187 (unshown results), i.e. the basal [Ca2]i
could be increased 5^10 times or up to 50^100 times with 0.1
and 1 WM A23187, respectively.
3.2. Platelet protein phosphorylation
The impact of the two di¡erent [Ca2]i levels on protein
phosphorylation was studied on 32P-labelled proteins and on
phosphotyrosine proteins (Fig. 2). Two di¡erent pro¢les were
obtained. The higher the [Ca2]i, the less phosphorylated pro-
teins were observed. At [Ca2]i9 1 WM (left panels), two pro-
teins were phosphorylated (Fig. 2A), i.e. p47 and p20 corre-
sponding to pleckstrin and myosin light chain, respectively
[14], and tyrosine proteins were phosphorylated (Fig. 2B).
When [Ca2]i was over 4 WM (right panels), 32P-labelled pro-
teins were initially phosphorylated in the ¢rst 20 s and pro-
gressively dephosphorylated thereafter (Fig. 2A). Most phos-
photyrosine proteins disappeared, including the prominent
kinase Src [15] (Fig. 2B). We con¢rmed that high [Ca2]i
causes cytoskeletal proteolysis [16]. On Coomassie blue-
Fig. 1. [Ca2]i during ionophore-induced platelet activation. Fura-2-loaded platelets were stimulated (arrow) by 0.05 WM (left) or 0.5 WM (right)
ionomycin and [Ca2]i was registered. Results are expressed in WM of [Ca2]i within platelets and are representative of 5^7 experiments.
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stained gel, bands of 200 kDa and above disappeared and new
bands were visualized (Fig. 2C, right panel).
3.3. The e¡ect of inhibitors on protein phosphorylation
The protein dephosphorylation observed at high [Ca2]i
suggested that phosphatases were activated. We therefore
used the phosphatase inhibitors OA and pervanadate to in-
hibit serine/threonine phosphatases and tyrosine phospha-
tases, respectively. Because of the degradation of high molec-
ular weight proteins occurring at high [Ca2]i, we also used
calpeptin, the membrane permeant calpain inhibitor.
Pre-incubation with OA increased the basal protein phos-
phorylation state (Fig. 3A) and prevented high [Ca2]i-in-
duced dephosphorylation of p47 and p20, but not that of
high molecular weight proteins. Calpeptin prevented the dis-
appearance of high molecular weight 32P-labelled proteins,
but had no e¡ect on p47 and p20 dephosphorylation. Thus,
the phosphorylation of high molecular weight proteins and
the phosphorylation of p47 and p20 required that OA acted
in concert with calpeptin.
The addition of pervanadate to platelets before stimulation
at high [Ca2]i partly prevented dephosphorylation of tyrosine
proteins (Fig. 3B, compare to Fig. 2B, right panel). Calpeptin
had only a minimal e¡ect except for some recovery of Src
phosphorylation. The combination of pervanadate and cal-
peptin not only prevented dephosphorylation, but also al-
lowed some tyrosine phosphorylation. The latter result was
almost similar to that observed following stimulation by
most other agonists [17] (Fig. 2B, left panel), except for the
absence of the doublet of 97^110 kDa proteins, known to be
strictly dependent on platelet aggregation [18].
3.4. Tyrosine phosphatase and tyrosine kinase activities
Since the massive protein dephosphorylation concerned
more drastically tyrosine rather than serine/threonine-phos-
phorylated proteins, we studied the relationship between gross
platelet PTP and PTK activities and the [Ca2]i level. The
activities were also measured in the presence of calpeptin.
Activation increased the basal platelet PTP activity what-
ever the [Ca2]i level (Fig. 4). By contrast, the basal PTK
activity was increased at [Ca2]i9 1 WM, but not at [Ca2]iv
4 WM. In the latter conditions, pre-incubation with calpeptin
had no signi¢cant e¡ect on the PTP activity, but increased the
PTK activity to a level comparable to that observed at low
[Ca2]i. The results suggest that at [Ca2]iv 4 WM, PTKs were
inactivated by calpain.
Fig. 2. Platelet protein phosphorylation and [Ca2]i relationship. Platelets were stimulated by A23187 0.1 WM (left panels) or 1 WM (right pan-
els) for the indicated times. (A) Autoradiography of a gel from 32P-labelled platelet proteins resolved by SDS-PAGE on a 13% gel. Positions of
pleckstrin (p47) and myosin light chain (p20) are indicated. (B) Western blots of phosphotyrosine proteins from unlabelled platelets. After
SDS-PAGE on a 7% gel, transfer to a PDVF membrane and an immunoblot with 4G10, phosphotyrosine proteins were revealed with the ECL
system. (C) Coomassie blue of platelet proteins separated on a 10% gel. Arrows indicate new bands generated. Results are representative of
5^7 experiments.
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4. Discussion
We investigated the relationship between [Ca2]i, protein
phosphorylation and the balance between PTP and PTK ac-
tivities. We showed that during stimulation at high [Ca2]i, up
to 50^100 times the basal level, phosphoproteins disappear by
calpain-induced inactivation of PTKs rather than by stimula-
tion of PTPs, whose activity is increased whatever the eleva-
tion of [Ca2]i.
During platelet stimulation at [Ca2]i9 1 WM, several kin-
ases are activated, protein kinase C, the calcium/calmodulin-
dependent kinase that phosphorylates the myosin light chain
and tyrosine kinases [12,17]. By contrast, at [Ca2]iv 4 WM,
all proteins including phospho-serine and -threonine proteins
became less phosphorylated than in unstimulated platelets.
Pleckstrin was initially phosphorylated, but could not be
maintained in the phosphorylated form. Dephosphorylation
of subsets of tyrosine proteins [8] or of most tyrosine proteins
[6] has been reported during A23187-induced stimulation.
Here, we show that dephosphorylation also involved phos-
pho-serine and -threonine proteins.
Activation of one or more phosphatase(s) by high [Ca2]i
could be responsible for the tipping of the balance between
kinases and phosphatases towards the disappearance of phos-
phoproteins. OA prevented pleckstrin (p47) and myosin light
chain (p20) dephosphorylation, but failed to restore the pres-
ence of high molecular weight proteins, which are phosphoryl-
ated [19] because these proteins were degraded. Indeed, the
kinetics of high molecular weight (200 kDa and over) protein
dephosphorylation followed their disappearance. As a result,
pre-incubation with calpeptin restored the presence of high
molecular weight phosphorylated proteins. A role for calpain
to down-regulate protein kinase C has been proposed [20].
Calpain alters by limited proteolysis protein kinase C [21]
and calcium/calmodulin-regulated enzymes [22,23]. Taken to-
gether, the results suggest that calpain contributes to the con-
trol of serine/threonine protein phosphorylation during plate-
let activation.
The massive protein dephosphorylation involved more dras-
tically and more rapidly tyrosine-phosphorylated proteins,
rather than phospho-serine and -threonine proteins. Platelet
PTP activity is indeed stimulated during ionophore-induced
stimulation [6,24,25]. We show that the gross PTP activity
was increased regardless of the [Ca2]i. The addition of per-
vanadate, or phenylarsine oxide (not shown), did not restore
the phosphorylation. Platelet PTP activity thus cannot explain
the phosphotyrosine protein dephosphorylation. By contrast,
the PTK activity was increased at [Ca2]i9 1 WM, but not at
high [Ca2]i. Moreover, the addition of calpeptin had no ef-
fect on the PTP activity, but restored the PTK activity. Thus,
a high [Ca2]i hindered PTK activity, as a result of calpain
activation. This is consistent with the observation that calpain
participates in tyrosine protein phosphorylation and dephos-
phorylation [26] and inactivates the prominent platelet tyro-
sine kinase Src [27]. The absence of phosphotyrosine proteins
was thus due to prevention of the PTK activity, which, at a
reduced level, could not compensate for the PTP activity to
allow some tyrosine phosphorylation of proteins.
In conclusion, during stimulation by ionophores in the pres-
ence of calcium leading to high [Ca2]i, gross PTK activity
was not induced. Pasquet et al. [6] reported that following
stimulation by a mixture of thrombin plus collagen, only a
subpopulation of platelets showed extensive dephosphoryla-
tion of tyrosine proteins. This subpopulation corresponded
to platelets that had shed microparticles. PTK inactivation
would thus occur only in a platelet subpopulation and result-
ing tyrosine phosphoprotein pro¢les of all platelets would
show phosphorylated proteins. Ionophores are much stronger
agonists than thrombin plus collagen and stimulate almost
every platelet to shed microparticles [28], inducing tyrosine
phosphoproteins to disappear. Calpain-dependent protein de-
phosphorylation might represent an irreversible deleterious
Fig. 3. E¡ects of phosphatase and calpain inhibitors on protein
phosphorylation. (A) Autoradiography of a gel from 32P-labelled
platelet proteins as in Fig. 2. Positions of plekstrin (p47) and myo-
sin light chain (p20) are indicated. Before stimulation for the indi-
cated times by 0.5 WM ionomycin, calpeptin (Calp, 100 Wg/ml) and
OA (0.5 WM) were incubated for 30 and 5 min, respectively. (B)
Western blot of phosphotyrosine proteins as in Fig. 2. The position
of the tyrosine kinase Src is indicated. Pervanadate (Perv, 100 WM)
and calpeptin (Calp, 100 Wg/ml) were pre-incubated for 1 and
30 min, respectively. Results are representative of 3^5 experiments.
Fig. 4. Platelet PTP and PTK activities. Platelets were either unstim-
ulated (resting) or stimulated by 0.1 WM A23187 (Ca29 1 WM) or
by 1 WM A23187 (Ca2v 4 WM) for 2 min in the presence of 2 mM
CaCl2 at 37‡C with constant stirring. Calpeptin (100 Wg/ml) or
vehicle (Me2SO) was pre-incubated for 30 min. PTP activity (left)
was measured by the generation of p-nitrophenolate from pNPP
and measured by the absorbance at 405 nm and registered for
30 min. PTK activity (right) was measured by the phosphorylation
of a biotin-labelled tyrosine containing peptide and is expressed as
the absorbance A at 405/490 nm. Results are mean þ S.E.M. of
seven experiments (t-test: * = P9 0.05, ** = P9 0.005).
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process of proteolysis of signalling enzymes, including kinases,
resembling the apoptosis of nucleated cells [29].
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